92 related articles for article (PubMed ID: 11960746)
1. A novel lipid compound, epolactaene, induces apoptosis: its action is modulated by its side chain structure.
Nakai J; Kawada K; Nagata S; Kuramochi K; Uchiro H; Kobayashi S; Ikekita M
Biochim Biophys Acta; 2002 Mar; 1581(1-2):1-10. PubMed ID: 11960746
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis-inducing effect of epolactaene derivatives on BALL-1 cells.
Kuramochi K; Matsui R; Matsubara Y; Nakai J; Sunoki T; Arai S; Nagata S; Nagahara Y; Mizushina Y; Ikekita M; Kobayashi S
Bioorg Med Chem; 2006 Apr; 14(7):2151-61. PubMed ID: 16298530
[TBL] [Abstract][Full Text] [Related]
3. Syntheses and applications of fluorescent and biotinylated epolactaene derivatives: Epolactaene and its derivative induce disulfide formation.
Kuramochi K; Yukizawa S; Ikeda S; Sunoki T; Arai S; Matsui R; Morita A; Mizushina Y; Sakaguchi K; Sugawara F; Ikekita M; Kobayashi S
Bioorg Med Chem; 2008 May; 16(9):5039-49. PubMed ID: 18375133
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of epolactaene derivatives: structural requirements for inhibition of Hsp60 chaperone activity.
Nagumo Y; Kakeya H; Yamaguchi J; Uno T; Shoji M; Hayashi Y; Osada H
Bioorg Med Chem Lett; 2004 Sep; 14(17):4425-9. PubMed ID: 15357965
[TBL] [Abstract][Full Text] [Related]
5. Epolactaene, a novel neuritogenic compound in human neuroblastoma cells, selectively inhibits the activities of mammalian DNA polymerases and human DNA topoisomerase II.
Mizushina Y; Kobayashi S; Kuramochi K; Nagata S; Sugawara F; Sakaguchi K
Biochem Biophys Res Commun; 2000 Jul; 273(2):784-8. PubMed ID: 10873681
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of epolactaene analogs as DNA polymerases inhibitors.
Kuramochi K; Mizushina Y; Nagata S; Sugawara F; Sakaguchi K; Kobayashi S
Bioorg Med Chem; 2004 May; 12(9):1983-9. PubMed ID: 15080901
[TBL] [Abstract][Full Text] [Related]
7. Structural analysis of epolactaene derivatives as DNA polymerase inhibitors and anti-inflammatory compounds.
Mizushina Y; Kuramochi K; Ikawa H; Kuriyama I; Shimazaki N; Takemura M; Oshige M; Yoshida H; Koiwai O; Sugawara F; Kobayashi S; Sakaguchi K
Int J Mol Med; 2005 May; 15(5):785-93. PubMed ID: 15806299
[TBL] [Abstract][Full Text] [Related]
8. Transformation of thiols to disulfides by epolactaene and its derivatives.
Kuramochi K; Sunoki T; Tsubaki K; Mizushina Y; Sakaguchi K; Sugawara F; Ikekita M; Kobayashi S
Bioorg Med Chem; 2011 Jul; 19(14):4162-72. PubMed ID: 21708466
[TBL] [Abstract][Full Text] [Related]
9. Epolactaene binds human Hsp60 Cys442 resulting in the inhibition of chaperone activity.
Nagumo Y; Kakeya H; Shoji M; Hayashi Y; Dohmae N; Osada H
Biochem J; 2005 May; 387(Pt 3):835-40. PubMed ID: 15603555
[TBL] [Abstract][Full Text] [Related]
10. Epolactaene, a novel neuritogenic compound in human neuroblastoma cells, produced by a marine fungus.
Kakeya H; Takahashi I; Okada G; Isono K; Osada H
J Antibiot (Tokyo); 1995 Jul; 48(7):733-5. PubMed ID: 7649877
[No Abstract] [Full Text] [Related]
11. Epo-C12 inhibits peroxiredoxin 1 peroxidase activity.
Yoda T; Furuta M; Tsutsumi T; Ikeda S; Yukizawa S; Arai S; Morita A; Yamatoya K; Nakata K; Tomoshige S; Ohgane K; Furuyama Y; Sakaguchi K; Sugawara F; Kobayashi S; Ikekita M; Kuramochi K
Bioorg Med Chem; 2021 Jul; 41():116203. PubMed ID: 34015702
[TBL] [Abstract][Full Text] [Related]
12. Neuritogenic effect of epolactaene derivatives on human neuroblastoma cells which lack high-affinity nerve growth factor receptors.
Kakeya H; Onozawa C; Sato M; Arai K; Osada H
J Med Chem; 1997 Feb; 40(4):391-4. PubMed ID: 9046328
[No Abstract] [Full Text] [Related]
13. Diastereoselective total synthesis of both enantiomers of epolactaene.
Hayashi Y; Kanayama J; Yamaguchi J; Shoji M
J Org Chem; 2002 Dec; 67(26):9443-8. PubMed ID: 12492351
[TBL] [Abstract][Full Text] [Related]
14. Selective synthesis of epolactaene featuring efficient construction of methyl (Z)-2-iodo-2-butenoate and (2R,3S,4S)-2-trimethylsilyl-2,3-epoxy-4-methyl- gamma-butyrolactone.
Tan Z; Negishi E
Org Lett; 2006 Jun; 8(13):2783-5. PubMed ID: 16774256
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis in the human promyelocytic leukemia cell line HL60 by falconensone A and its derivatives, new polyenes.
Takahashi N; Kubo Y; Iwahori A; Kawai KI; Fukui T
Biol Pharm Bull; 2000 Jun; 23(6):748-54. PubMed ID: 10864029
[TBL] [Abstract][Full Text] [Related]
16. Pramanicin induces apoptosis in Jurkat leukemia cells: a role for JNK, p38 and caspase activation.
Kutuk O; Pedrech A; Harrison P; Basaga H
Apoptosis; 2005 May; 10(3):597-609. PubMed ID: 15909121
[TBL] [Abstract][Full Text] [Related]
17. Chain elongation analog of resveratrol as potent cancer chemoprevention agent.
Kang YF; Qiao HX; Xin LZ; Ge LP
J Physiol Biochem; 2016 Sep; 72(3):445-52. PubMed ID: 27160168
[TBL] [Abstract][Full Text] [Related]
18. Induction of mitochondria-involved apoptosis in estrogen receptor-negative cells by a novel tamoxifen derivative, ridaifen-B.
Nagahara Y; Shiina I; Nakata K; Sasaki A; Miyamoto T; Ikekita M
Cancer Sci; 2008 Mar; 99(3):608-14. PubMed ID: 18167132
[TBL] [Abstract][Full Text] [Related]
19. Relationship Between Structure and Antiproliferative Activity of Novel 5-amino-4-cyanopyrazole-1-formaldehydehydrazono Derivatives on HL-60RG Human Leukemia Cells.
Nagahara Y; Nagahara K
Anticancer Res; 2017 Nov; 37(11):6329-6333. PubMed ID: 29061816
[TBL] [Abstract][Full Text] [Related]
20. Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines and leukemia.
Zhelev Z; Ohba H; Bakalova R; Hadjimitova V; Ishikawa M; Shinohara Y; Baba Y
Cancer Chemother Pharmacol; 2004 Mar; 53(3):267-75. PubMed ID: 14663628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
